Cerebral Palsy Epidemiology Forecast Insight
DelveInsight’s ‘Cerebral Palsy - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted cerebral palsy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
Study Period: 2018–2030
Cerebral Palsy Understanding
A cerebral palsy is a group of disorders that affect movement and muscle tone or posture. It is caused by damage that occurs to the immature brain as it develops, most often before birth. This condition can cause problems with posture, gait (manner of walking), muscle tone, and coordination of movement. Depending on how the condition is managed, motor skills can improve or worsen over time. The specific forms of cerebral palsy are determined by the extent, type, and location of a child’s abnormalities. The types include spastic cerebral palsy, dyskinetic cerebral palsy, ataxic cerebral palsy, and mixed cerebral palsy.
The most common type of cerebral palsy is spastic cerebral palsy. People with spastic cerebral palsy have increased muscle tone, meaning their muscles are stiff, and, as a result, their movements can be awkward. Moreover, dyskinetic cerebral palsy causes problems in controlling the movement of hands, arms, feet, and legs, making it difficult to sit and walk. The movements are uncontrollable and can be slow and writhing or rapid and jerky. Ataxic cerebral palsy is the rarest form and predominately impairs balance and coordination. These patients walk with a wide-based gait and have intentional tremors. Mixed types of cerebral palsy refer to symptoms that do not correspond to any single type of cerebral palsy but are a mix of types. Some people have symptoms of more than one type of cerebral palsy. The symptoms of cerebral palsy vary from person to person. A person with a mild condition, might walk a little awkwardly but might not need any special help. A person with severe cerebral palsy might need to use special equipment to walk or might not be able to walk at all and might need lifelong care. Cerebral palsy does not get worse over time, though the exact symptoms can change over a person’s lifetime.
The majority of children have congenital cerebral palsy, that is, they were born with it. However, a small number of children have acquired cerebral palsy, which means the disorder begins after birth. Some causes of acquired cerebral palsy include brain damage in the first few months or years of life, brain infections such as bacterial meningitis or viral encephalitis, problems with blood flow to the brain, or head injury from a motor vehicle accident, a fall, or child abuse.
Cerebral Palsy Diagnosis
The testing strategy is based on the clinical picture, the pattern of development of symptoms, family history, and other factors influencing the probability of specific diagnoses. Surveillance for associated disabilities such as hearing and vision impairment, seizures, perception problems with touch or pain, and cognitive dysfunction can help complete the clinical assessment and determine the diagnosis. Several assessment instruments are available to quantify and monitor developmental milestones and skills and to assess the quality of life of patients and their caregivers.
Cerebral palsy is usually diagnosed anywhere between 18 months and 5 years of age. A cerebral palsy diagnosis is made using imaging tests to observe any form of brain damage. The imaging tests include cranial ultrasounds, computed tomography scans (CT), electroencephalograms (EEG), and magnetic resonance imaging (MRI).
Epidemiology Perspective by DelveInsight
The Cerebral Palsy epidemiology division provides insights about the historical and current cerebral palsy patient pool and forecasted trends for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
In the year 2020, the total prevalent case of cerebral palsy was 1.8 million cases in the 7MM which are expected to grow during the study period, i.e., 2018–2030.
The disease epidemiology covered in the report provides historical as well as forecasted cerebral palsy epidemiology [segmented as Total Prevalent Cases of Cerebral Palsy, Total Diagnosed Cases of Cerebral Palsy, Total Type-specific cases of Cerebral Palsy, and Treated cases of Cerebral Palsy] in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2018 to 2030.
Country Wise- Cerebral Palsy Epidemiology
- Estimates show that the highest cases of cerebral palsy in the 7MM were in the United States, followed by Japan, the United Kingdom, Germany, France, Spain, and Italy in 2020.
- In the United States, the total number of prevalent cases of cerebral palsy was approximately 1 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.
- In the year 2020, the total prevalent cases of cerebral palsy were approximately 0.7 million cases in EU-5 which are expected to grow during the study period, i.e., 2018–2030.
- In Japan, the total number of prevalent cases of cerebral palsy was approximately 0.2 million cases in the year 2020 which are expected to grow during the study period, i.e., 2018–2030.
Scope of the Report
- The Cerebral Palsy report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns.
- The Cerebral Palsy Report and Model provide an overview of the risk factors and global trends of Cerebral Palsy in the seven major markets (7MM: The United States, Germany, France, Italy, Spain, and the United Kingdom, and Japan)
- The report provides insight about the historical and forecasted patient pool of Cerebral Palsy in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
- The report helps to recognize the growth opportunities in the 7MM concerning the patient population.
- The report assesses the disease risk and burden and highlights the unmet needs of Cerebral Palsy.
- The report provides the segmentation of the Cerebral Palsy epidemiology by total prevalent cases in the 7MM.
- The report provides the segmentation of the Cerebral Palsy epidemiology by total diagnosed cases in the 7MM.
- The report provides the segmentation of the Cerebral Palsy epidemiology by total type-specific cases in the 7MM.
- The report provides the segmentation of the Cerebral Palsy epidemiology by treated cases in the 7MM.
- 10-Year Forecast of Cerebral Palsy epidemiology
- 7MM Coverage
- Total Prevalent Cases of Cerebral Palsy
- Total Diagnosed Cases of Cerebral Palsy
- Total Type-Specific Cases of Cerebral Palsy
- Treated Cases of Cerebral Palsy
We interview KOL’s and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.
Key Questions Answered
- What will be the growth opportunities in the 7MM concerning the patient population of Cerebral Palsy?
- What are the key findings of the Cerebral Palsy epidemiology across the 7MM and which country will have the highest number of patients during the study period (2018–2030)?
- What would be the total number of patients of Cerebral Palsy across the 7MM during the study period (2018–2030)?
- Among the EU5 countries, which country will have the highest number of patients during the study period (2018–2030)?
- At what CAGR the patient population is expected to grow in the 7MM during the study period (2018–2030)?
- What are the various recent and upcoming events which are expected to improve the diagnosis of Cerebral Palsy?
Reasons to buy
The Cerebral Palsy Epidemiology report will allow the user to -
- Develop business strategies by understanding the trends shaping and driving the global Cerebral Palsy market
- Quantify patient populations in the global Cerebral Palsy market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the gender that presents the best opportunities for Cerebral Palsy therapeutics in each of the markets covered
- Understand the magnitude of the Cerebral Palsy population by its severity
- The Cerebral Palsy epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists
- The Cerebral Palsy Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over an 10-year forecast period using reputable sources
- Patient Segmentation
- Disease Risk and Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
1. Key Insights
2. Report Introduction
3. Executive Summary of Cerebral Palsy
4. Epidemiology Methodology
5. Disease Background and Overview
5.2. Types of Cerebral Palsy
5.3. Classification System of Cerebral Palsy
5.4. Signs and Symptoms of Cerebral Palsy
5.5. Risk Factors and Causes of Cerebral Palsy
5.6. Pathophysiology of Cerebral Palsy
5.7. Complications of Cerebral Palsy
6. Diagnosis of Cerebral Palsy
6.1. Diagnostic Algorithm
6.2. Screening of Newborns
6.3. Observational Diagnosis
6.4. Imaging Tests
6.5. Genetic Testing
6.6. Differential Diagnosis
7. Diagnostic Guidelines of Cerebral Palsy
7.1. National Institute for Health and Care Excellence (NICE) assessment guidelines in under 25s
7.2. Diagnostic Assessment of the Child With Cerebral Palsy – American Academy of Neurology and the Practice Committee of the Child Neurology Society
8. Epidemiology and Patient Population
8.1. Key Findings
8.2. Epidemiology of Cerebral Palsy
8.3. Epidemiology Scenario
8.3.1. Total Prevalent Cases of Cerebral Palsy
8.3.2. Total Diagnosed Cases of Cerebral Palsy
8.3.3. Total Type-specific Cases of Cerebral Palsy
9.2. Report Methodology
10. DelveInsight Capabilities
12. About DelveInsight
List of Table
Table 1: Summary of Cerebral Palsy Epidemiology (2018–2030)
Table 2: Classification Based on Gross Motor Function Classification System
Table 3: Independent Risk Factors FOR Cerebral Palsy
Table 4: Total Prevalent Cases of Cerebral Palsy in 7MM (2018–2030)
Table 5: Total Diagnosed Cases of Cerebral Palsy in 7MM (2018–2030)
Table 6: Total Type-specific Cases of Cerebral Palsy in 7MM (2018–2030)
List of Figures
Figure 1: Epidemiology Methodology
Figure 2: Types of Cerebral Palsy
Figure 3: Signs and Symptoms
Figure 4: Causes and Risk Factors of Cerebral Palsy
Figure 5: Casual Factors of Cerebral Palsy Between 20 Weeks of Gestation Period
Figure 6: Main sites and Types of Genetic Variation in Cerebral Palsy
Figure 7: Diagnostic Algorithm
Figure 8: Cranial Ultrasound
Figure 9: Total Prevalent Cases of Cerebral Palsy in the 7MM (2018–2030)
Figure 10: Total Diagnosed Cases of Cerebral Palsy in the 7MM (2018–2030)
Figure 11: Total Type-specific Cases of Cerebral Palsy in the 7MM (2018–2030)